Gene Set Enrichment Analysis in Zebrafish Embryos Is Susceptible to False-Positive Results in the Absence of

John Dh Stead1, Hyojin Lee2, Andrew Williams3

  • 1Department of Neuroscience, Carleton University, Ottawa, ON, Canada.

Insights

Gene Set Enrichment Analysis (GSEA) can produce false-positive pathway enrichments, particularly in toxicology studies with few differentially expressed genes (DEGs). Researchers should exercise caution when interpreting GSEA results, especially when no DEGs are detected.

Area of Science:

  • Toxicology
  • Pharmacology
  • Bioinformatics
  • Gene Expression Analysis

Background:

  • High-throughput gene expression studies utilize pathway analysis to interpret differentially expressed genes (DEGs).
  • In toxicology and pharmacology, treatment groups are compared to vehicle controls to identify DEGs and altered pathways.
  • Previous work quantified false-positive rates of DEGs in zebrafish embryos to guide study design.

Purpose of the Study:

  • To identify false-positive enriched pathways using Over-Representation Analysis (ORA) and Gene Set Enrichment Analysis (GSEA) in zebrafish embryo gene expression data.
  • To investigate the impact of sample and pool size on false-positive rates in GSEA.
  • To elucidate mechanisms driving GSEA false-positives and assess generalizability across algorithms and statistics.

Main Methods:

  • Applied ORA and GSEA (specifically, the fast GSEA (fgsea) algorithm) to existing gene expression data from vehicle-treated zebrafish embryos.
  • Analyzed data under varying sample and pool sizes, including conditions with zero DEGs.
  • Repeated GSEA using an alternative algorithm (CERNO) and 11 different ranking statistics.

Main Results:

  • False-positive ORA rates decreased with larger sample and pool sizes.
  • GSEA false-positive rates, particularly with fgsea, increased with sample and pool size, peaking when zero DEGs were detected.
  • Ribosomal gene sets were most frequently and falsely enriched in GSEA, especially under low-expression-difference conditions.
  • These GSEA findings were consistent across different algorithms and ranking statistics.

Conclusions:

  • GSEA can generate misleading pathway enrichments, especially in scenarios with minimal or no DEGs.
  • The frequency of false-positive GSEA results is influenced by experimental design parameters like sample and pool size.
  • Caution is advised when interpreting GSEA results in toxicological and pharmacological studies, particularly when contrasts yield no significant DEGs.